An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease

Shi Du Yan(Columbia University), David M. Stern(Augusta University), Eric Stern(Columbia University), Kate S. Collison(King Faisal Specialist Hospital & Research Centre), Claudio Soto(The University of Texas Health Science Center at Houston), Alex E. Roher(Barrow Neurological Institute), Xi Chen(Beijing Jiaotong University), Futwan Al‐Mohanna(King Faisal Specialist Hospital & Research Centre), Huaijie Zhu(Columbia University), Aiping Zhu(Columbia University), Masaya Tohyama(Institute for Women's Policy Research), Jin Fu(Columbia University), Satoshi Ogawa(The University of Osaka), Takaomi C. Saido(RIKEN Center for Brain Science)
Nature
October 1, 1997
10.1038/39522
Cited by 376

Related Papers

RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
|Nature|1996|2k
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
|American Journal Of Pathology|1999|1.5k
The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques
|Cell Reports|2019|978
Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease
|Cell|2020|955
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
|Nature|2000|941